Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 2Recruiting 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1

Conditions

Malignant Neoplasms of Independent (Primary) Multiple Sites 1Esophageal Neoplasms 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Electrocardiography, Ambulatory × Clear all
NCT04835987 2023-11-24

PROSNACO

Centre Hospitalier Universitaire de Saint Etienne

Withdrawn
Gastrointestinal

Esophageal Neoplasms

NCT03177681 2023-03-27

The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) Symptoms

M.D. Anderson Cancer Center

Phase NA Withdrawn
Other neoplasm

Malignant Neoplasms of Independent (Primary) Multiple Sites

Data powered by HemOnc (CC BY 4.0) Colophon âš¡